Results 21 to 30 of about 89 (80)

Consensus Guideline for the Diagnosis and Treatment of Tyrosine Hydroxylase (TH) Deficiency

open access: yesJournal of Inherited Metabolic Disease, Volume 48, Issue 6, November 2025.
ABSTRACT Tyrosine hydroxylase (TH) catalyses the rate‐limiting step in dopamine biosynthesis. Autosomal recessive tyrosine hydroxylase deficiency (THD) leads to clinical phenotypes reflecting the deficiency of dopamine, norepinephrine, or epinephrine in the central nervous system (CNS), presenting along a continuous spectrum from mild to severe forms ...
Mariya Sigatullina Bondarenko   +41 more
wiley   +1 more source

Oculogyric crisis as an initial manifestation of Wilson’s disease

open access: yesNeurology, 1999
Wilson’s disease is an autosomal-recessive inherited disease caused by a defect on chromosome 13 encoding copper transporting P-type adenosine triphosphatase. Although patients with Wilson’s disease have a fundamental defect in the hepatobiliary system, they have various combinations of neurologic, psychiatric, and musculoskeletal manifestations.
M S, Lee, Y D, Kim, C H, Lyoo
openaire   +3 more sources

WWOX Mutation as a Rare Cause of Neonatal‐Infantile Parkinsonism Mimicking a Neurotransmitter Disorder: A Case Report

open access: yes
Journal of Paediatrics and Child Health, Volume 62, Issue 7, Page 1273-1277, July 2026.
Ozge Serce Pehlevan   +3 more
wiley   +1 more source

Development and Preliminary Validation of a Parkinsonism‐Dystonia Scale for Infants and Young Children

open access: yesMovement Disorders, Volume 40, Issue 8, Page 1669-1679, August 2025.
Abstract Background Parkinsonism in infancy is rare and is highly correlated with the presence of dystonia. Advances in treating and characterizing developmental and infantile degenerative parkinsonism have highlighted the need for a specialized assessment scale.
Roser Pons   +16 more
wiley   +1 more source

An Unusual Motor OFF in Parkinson's Disease

open access: yes
Movement Disorders Clinical Practice, Volume 13, Issue 4, Page 1085-1087, April 2026.
Shreyashi Jha, Mandar S. Jog
wiley   +1 more source

Early Levodopa Therapy in Tyrosine Hydroxylase Deficiency

open access: yes
Movement Disorders Clinical Practice, Volume 12, Issue 12, Page 2353-2356, December 2025.
Claudio M. de Gusmao   +4 more
wiley   +1 more source

Tardive oculogyric crisis associated with amisulpride monotherapy

open access: yesJournal of Postgraduate Medicine, 2010
Oculogyric crisis (OGC) is a dystonic and distressing side- effect which occurs immediately after the administration of high-potency antipsychotic drugs and is usually reported as a subtype of dystonia. We report a case of a young woman with schizophrenia who presented with tardive OGC related to amisulpride.
Mendhekar, D.N., Lohia, D., Kataria, P.
openaire   +2 more sources

Blepharospasm in GNAO1 Syndrome May Benefit From Botulinum Toxins

open access: yes
Movement Disorders Clinical Practice, Volume 12, Issue 11, Page 2007-2009, November 2025.
Eleonora Minacapilli   +4 more
wiley   +1 more source

Involuntary Eye Movements as a Clue to Diagnosis

open access: yes
Movement Disorders Clinical Practice, Volume 12, Issue 10, Page 1662-1663, October 2025.
Victor Rebelo Procaci   +4 more
wiley   +1 more source

Aripiprazole-induced oculogyric crisis (acute dystonia)

open access: yesJournal of Pharmacology and Pharmacotherapeutics, 2012
Aripiprazole is the third generation atypical antipsychotic and a dopamine serotonin system stabilizer (DSS) effective against positive and negative symptoms of schizophrenia. It has a low propensity for extrapyramidal side effects, causes minimal weight gain or sedation, produces no elevation in serum prolactin levels, and does not cause prolongation ...
openaire   +3 more sources

Home - About - Disclaimer - Privacy